For: | Gong J, Chuang J, Cho M, Toomey K, Hendifar A, Li D. Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E5232. [PMID: 32718047 DOI: 10.3390/ijms21155232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Park HJ, Choi G, Ha S, Kim Y, Choi M, Kim M, Islam MK, Chang Y, Kwon T, Kim D, Jang E, Kim TH, Chang SJ, Kim Y. MBP-11901 Inhibits Tumor Growth of Hepatocellular Carcinoma through Multitargeted Inhibition of Receptor Tyrosine Kinases. Cancers 2022;14:1994. [DOI: 10.3390/cancers14081994] [Reference Citation Analysis] |
2 | Larasati Y, Boudou C, Koval A, Katanaev VL. Unlocking the Wnt pathway: Therapeutic potential of selective targeting FZD7 in cancer. Drug Discov Today 2021:S1359-6446(21)00542-0. [PMID: 34915171 DOI: 10.1016/j.drudis.2021.12.008] [Reference Citation Analysis] |
3 | Niu M, Yi M, Li N, Wu K, Wu K. Advances of Targeted Therapy for Hepatocellular Carcinoma. Front Oncol 2021;11:719896. [PMID: 34381735 DOI: 10.3389/fonc.2021.719896] [Reference Citation Analysis] |